Vanda Pharmaceuticals Inc. - COM (VNDA)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
46.3 M
Holdings value Q1 2024
$190 M
Value change Q1 2024
-$9.65 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
133
Number of buys Q1 2024
58
Number of sells Q1 2024
-90
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
921659108
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 46.3 M $190 M -$9.65 M $4.11 133
2023 Q4 48.6 M $205 M -$19.8 M $4.22 152
2023 Q3 52.4 M $227 M -$23 M $4.32 176
2023 Q2 55.9 M $368 M -$15.1 M $6.59 180
2023 Q1 58.1 M $394 M +$16.9 M $6.79 173
2022 Q4 55.4 M $409 M +$13.8 M $7.39 182
2022 Q3 41.7 M $412 M -$11.4 M $9.88 162
2022 Q2 55.3 M $602 M -$3.4 M $10.90 160
2022 Q1 55.8 M $632 M +$19 M $11.31 177
2021 Q4 53.4 M $838 M -$31.8 M $15.69 187
2021 Q3 55.2 M $945 M +$5.22 M $17.14 174
2021 Q2 54.1 M $1.16 B -$3.36 M $21.51 177
2021 Q1 54 M $812 M -$4.93 M $15.02 178
2020 Q4 54.5 M $717 M +$6.5 M $13.14 166
2020 Q3 54 M $521 M -$8.78 M $9.66 153
2020 Q2 54.6 M $625 M +$15.8 M $11.44 155
2020 Q1 53.4 M $554 M +$24 K $10.36 149
2019 Q4 52 M $854 M -$1.86 M $16.41 166
2019 Q3 52.1 M $692 M -$17.1 M $13.28 156
2019 Q2 54 M $761 M +$14.2 M $14.09 154
2019 Q1 54 M $994 M +$8.47 M $18.40 170
2018 Q4 52.8 M $1.38 B +$26.9 M $26.13 180
2018 Q3 52.2 M $1.2 B +$79.4 M $22.95 158
2018 Q2 49 M $934 M +$18.6 M $19.05 134
2018 Q1 48.2 M $812 M +$129 M $16.85 131
2017 Q4 40.7 M $619 M +$12.4 M $15.20 126
2017 Q3 39.7 M $710 M +$17.9 M $17.90 137
2017 Q2 38.8 M $633 M -$6.21 M $16.30 131
2017 Q1 39.5 M $552 M +$44 M $14.00 134
2016 Q4 40.6 M $648 M -$10.1 M $15.95 140
2016 Q3 38.9 M $647 M +$67.5 M $16.64 136
2016 Q2 37.2 M $417 M -$42.2 M $11.19 114
2016 Q1 41.3 M $345 M -$12.8 M $8.36 115
2015 Q4 42.6 M $396 M -$31.3 M $9.31 115
2015 Q3 42.7 M $482 M -$256 K $11.28 120
2015 Q2 42 M $533 M -$34.8 M $12.69 108
2015 Q1 46.2 M $430 M -$27.6 M $9.30 107
2014 Q4 47.6 M $681 M +$76.4 M $14.32 109
2014 Q3 41.3 M $428 M +$24.1 M $10.38 101
2014 Q2 38.5 M $622 M +$52.9 M $16.18 111
2014 Q1 35.2 M $571 M +$57.3 M $16.25 110